vs
合众银行（OSBC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$93.8M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 15.1%）
合众银行是一家总部位于美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押等金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
OSBC vs PBYI — 直观对比
营收规模更大
OSBC
是对方的1.2倍
$75.5M
两年增速更快
PBYI
近两年复合增速
15.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.8M | $75.5M |
| 净利润 | $25.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 27.3% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 159.2% | — |
| 每股收益（稀释后） | $0.48 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OSBCPBYI
| Q1 26 | $93.8M | — | ||
| Q4 25 | $95.2M | $75.5M | ||
| Q3 25 | $95.9M | $54.5M | ||
| Q2 25 | $75.1M | $52.4M | ||
| Q1 25 | $73.1M | $46.0M | ||
| Q4 24 | $73.2M | $59.1M | ||
| Q3 24 | $71.2M | $80.5M | ||
| Q2 24 | $70.8M | $47.1M |
净利润OSBCPBYI
| Q1 26 | $25.6M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $9.9M | $8.8M | ||
| Q2 25 | $21.8M | $5.9M | ||
| Q1 25 | $19.8M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $23.0M | $20.3M | ||
| Q2 24 | $21.9M | $-4.5M |
毛利率OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 41.2% | 22.7% | ||
| Q3 25 | 13.6% | 17.6% | ||
| Q2 25 | 38.9% | 12.7% | ||
| Q1 25 | 35.8% | 8.7% | ||
| Q4 24 | 34.7% | 22.6% | ||
| Q3 24 | 41.9% | 27.4% | ||
| Q2 24 | 41.2% | -4.6% |
净利率OSBCPBYI
| Q1 26 | 27.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 10.3% | 16.2% | ||
| Q2 25 | 29.0% | 11.2% | ||
| Q1 25 | 27.1% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.3% | 25.2% | ||
| Q2 24 | 30.9% | -9.6% |
每股收益（稀释后）OSBCPBYI
| Q1 26 | $0.48 | — | ||
| Q4 25 | $0.53 | $0.26 | ||
| Q3 25 | $0.18 | $0.17 | ||
| Q2 25 | $0.48 | $0.12 | ||
| Q1 25 | $0.43 | $0.06 | ||
| Q4 24 | $0.42 | $0.40 | ||
| Q3 24 | $0.50 | $0.41 | ||
| Q2 24 | $0.48 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $893.3M | $130.3M |
| 总资产 | $6.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资OSBCPBYI
| Q1 26 | $115.7M | — | ||
| Q4 25 | $124.0M | $97.5M | ||
| Q3 25 | $116.5M | $94.4M | ||
| Q2 25 | $141.8M | $96.0M | ||
| Q1 25 | $256.1M | $93.2M | ||
| Q4 24 | $99.3M | $101.0M | ||
| Q3 24 | $115.8M | $96.7M | ||
| Q2 24 | $120.9M | $96.8M |
总债务OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益OSBCPBYI
| Q1 26 | $893.3M | — | ||
| Q4 25 | $896.8M | $130.3M | ||
| Q3 25 | $866.7M | $115.3M | ||
| Q2 25 | $718.6M | $104.7M | ||
| Q1 25 | $694.5M | $97.1M | ||
| Q4 24 | $671.0M | $92.1M | ||
| Q3 24 | $661.4M | $71.1M | ||
| Q2 24 | $619.3M | $48.5M |
总资产OSBCPBYI
| Q1 26 | $6.8B | — | ||
| Q4 25 | $6.9B | $216.3M | ||
| Q3 25 | $7.0B | $202.9M | ||
| Q2 25 | $5.7B | $194.9M | ||
| Q1 25 | $5.7B | $196.2M | ||
| Q4 24 | $5.6B | $213.3M | ||
| Q3 24 | $5.7B | $220.7M | ||
| Q2 24 | $5.7B | $205.0M |
负债/权益比OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | $122.3M | $14.4M | ||
| Q3 25 | $35.9M | $9.7M | ||
| Q2 25 | $24.2M | $14.1M | ||
| Q1 25 | $17.8M | $3.6M | ||
| Q4 24 | $131.5M | $15.6M | ||
| Q3 24 | $48.5M | $11.0M | ||
| Q2 24 | $11.6M | $1.0M |
自由现金流OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | $117.8M | $14.4M | ||
| Q3 25 | $34.7M | $9.7M | ||
| Q2 25 | $23.5M | $14.1M | ||
| Q1 25 | $16.2M | $3.6M | ||
| Q4 24 | $120.7M | $15.6M | ||
| Q3 24 | $46.2M | $11.0M | ||
| Q2 24 | $8.7M | $1.0M |
自由现金流率OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 123.7% | 19.1% | ||
| Q3 25 | 36.2% | 17.7% | ||
| Q2 25 | 31.2% | 26.8% | ||
| Q1 25 | 22.2% | 7.7% | ||
| Q4 24 | 165.0% | 26.4% | ||
| Q3 24 | 64.9% | 13.7% | ||
| Q2 24 | 12.3% | 2.1% |
资本支出强度OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 2.2% | 0.1% | ||
| Q4 24 | 14.7% | 0.0% | ||
| Q3 24 | 3.3% | 0.0% | ||
| Q2 24 | 4.2% | 0.0% |
现金转化率OSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.64× | 1.10× | ||
| Q2 25 | 1.11× | 2.41× | ||
| Q1 25 | 0.90× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 0.54× | ||
| Q2 24 | 0.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OSBC
| Net Interest Income | $81.1M | 87% |
| Noninterest Income | $12.6M | 13% |
PBYI
暂无分部数据
